Company Profiles

driven by the PitchBook Platform

Catylix

Description

Developer of catalysts and reagents for chemical synthesis. The company produces shelf-stable reagent for trifluoromethylation which have improved pharmacokinetic properties for medicinal, veterinary and agrochemical applications.

2011

Founded

PRIVATE

Status

1-10

Employees

Early Stage VC

Latest Deal Type

1

Investors

Description

Developer of catalysts and reagents for chemical synthesis. The company produces shelf-stable reagent for trifluoromethylation which have improved pharmacokinetic properties for medicinal, veterinary and agrochemical applications.

Website:

www.catylix.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Chemicals and Gases

Other Industries

Biotechnology

Primary Office

2001 South First Street Suite 201 Champaign, IL 61820United States +1 (818) 388-6576
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Catylix's full profile, request a free trial.

Catylix Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Catylix Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Illinois VenturesVenture CapitalMinority000 0000000 0000
Illinois Ventures Venture Capital

Catylix Executive Team (3)

NameTitleBoard
Seat
Contact
Info
David Rozzell Ph.DCo-Founder and Chief Executive Officer
Brian AdgerCo-Founder
John HartwigCo-Founder
David Rozzell Ph.D Co-Founder and Chief Executive Officer
Brian Adger Co-Founder
John Hartwig Co-Founder
Request full access to PitchBook